|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.04 CNY | +1.63% |
|
+3.92% | -7.95% |
| 07-12 | Fosun Pharma Receives Offers for Share Alternative Offer Related to Henlius Merger Offer | MT |
| 07-08 | Shanghai Fosun Pharmaceutical (Group) Cancer Treatment Gets NMPA's Nod for Clinical Trials | MT |
Shanghai FOSUN Pharmaceutical (Group) Co., Ltd. (SHSE:600196) will use the proceed of the share issue to repay interest-bearing debts, replenish the working capital of the group, and finance potential mergers and acquisitions domestically or overseas.
| 1st Jan change | Capi. | |
|---|---|---|
| -7.95% | 7.55B | |
| +55.35% | 848B | |
| +31.64% | 627B | |
| -0.10% | 363B | |
| +15.47% | 318B | |
| +13.10% | 299B | |
| +15.51% | 243B | |
| +16.72% | 225B | |
| +16.54% | 179B | |
| +4.31% | 167B |
SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. 
